Jack Goodman presented new results of Netgene CoLab's work on modeling cancer metabolism and patient survival on June 10 at the American Society of Clinical Oncology’s annual national meeting, organized in Chicago.
The abstract, “Differential Metabolic Pathway Activity Estimated From Tumor Gene Expression Predicts Prolonged Cancer Survival Across 23 Tissue Types,” by Netgene colab members Jack Goodman and Marcus Alexander was selected to be one of the three top highlighted out of 49 accepted nationally to the 2021 ASCO section for medical student and resident abstracts.
Jack and Marcus founded Netgene CoLab and started doing computational genomics research as first-year medical students at Netter at the start of this year. Their research utilizes large public-access data on tumor gene expression and advanced computational models to help better classify cancers by their metabolic profiles, improving prognosis of patient survival.
Netgene CoLab research will appear next on Aug 12 at the Joint Statistical Meetings (JSM), the largest annual meeting of statisticians in the world that is organized by the American Statistical Association. Jack Goodman will present his work with Marcus Alexander in the session titled "Next-Generation Sequencing and High-Dimensional Data" of the Biometrics Section of the ASA.